Author

Eric Ma

Oklahoma Medical Research Foundation

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

ANNA MARIA RANDIiD· 1 shared Behnam BadieiD· 1 shared Brenda AguilariD· 1 shared Christine E. BrowniD· 1 shared Christopher M. SchaferiD· 1 shared Courtney T. GriffiniD· 1 shared Floris P BartheliD· 1 shared Graeme M. BirdseyiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

ANNA MARIA RANDIORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Patient-Derived Glioma Models Preserve Tumor Heterogeneity and Identify Stearoyl-CoA Desaturase1 (SCD1) as a Candidate Biomarker for Precision Immunotherapy

Margarita Gutova, Eric Ma, Heini M. Natri, Sean M. Sepulveda, Sharvari Mankame, Spencer Uyematsu, Jonathan C. Hibbard, Maryam Aftabizadeh, Xiujian Ma, Renate Starr, Brenda Aguilar, Julie Ostberg, Lisa A. Feldman, Massimo D’Apuzzo, Nicholas E. Banovich, , Christine E. Brown

bioRxiv · Sep 3, 2026 · PreprintCancer Biology

Targeting endothelial ERG to mitigate vascular regression and neuronal ischemia in retinopathies

Eric Ma, Christopher M. Schafer, Jun Xie, Yelyzaveta Rudenko, John T. H. Knapp, ANNA MARIA RANDI, Graeme M. Birdsey, Courtney T. Griffin

This study shows that overexpressing ERG in endothelial cells prevents vascular regression and neuronal damage in OIR models, suggesting ERG as a potential therapeutic target for retinopathies.

Proceedings of the National Academy of Sciences · Sep 23, 2025Peer-reviewedPathology